This supplement explores the considerable burden of major bleeding events in patients receiving direct oral anticoagulation therapy and reviews the consensus guidelines pertaining to the management of this population. In addition, this supplement features perspectives from key medical and pharmacy stakeholders describing their organizations’ specific approaches to anticoagulation management.
This Supplement was Sponsored by Portola Pharmaceuticals
|Mauricio Concha, MD
Director, Comprehensive Stroke Center
Sarasota Memorial Hospital
|John Fanikos, RPh, MBA
Executive Director of Pharmacy Services
Brigham and Women’s Hospital